US Broker Ratings

Novavax, Inc. (NVAX) Stock Analysis: Evaluating a 36% Potential Upside in a Volatile Biotech Sector

Novavax, Inc. (NASDAQ: NVAX), a prominent player in the biotechnology sector, presents an intriguing opportunity for investors as it navigates the complexities of vaccine development and..

Neogen Corporation (NEOG) Stock Analysis: Navigating Growth Prospects Amid Market Challenges

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector specializing in medical devices, has captured investor attention with its diverse portfolio focused on food..

Privia Health Group, Inc. (PRVA) Stock Analysis: A 31.8% Upside Lures Investors in the Booming Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, is capturing the attention of investors with its innovative approach to physician enablement..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring the 33% Potential Upside

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is a dynamic player in the biotechnology sector, headquartered in Cambridge, Massachusetts. The company is renowned for its innovative approach to..

Viridian Therapeutics, Inc. (VRDN): Investor Outlook on a Biotech Powerhouse with 38% Upside Potential

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has emerged as a compelling player in the biotechnology sector with its innovative approach to addressing serious and rare diseases. With..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Strong Buy Ratings Signal Potential 73% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is capturing investor interest with its significant growth potential in the biotechnology sector. The company, with its $4.44 billion market cap,..

Evotec SE (EVO) Stock Analysis: Exploring a Potential 67.92% Upside Amidst Financial Challenges

Evotec SE (EVO) presents a compelling case for investors willing to navigate the complexities of the healthcare sector, specifically within drug manufacturing. Headquartered in Hamburg, Germany,..

Dynavax Technologies Corporation (DVAX): Investor Outlook with a Focus on Revenue Growth and Market Position

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector with a robust focus on vaccine development and commercialization. As a commercial-stage biopharmaceutical company,..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Is a 59% Upside Within Reach?

Pulse Biosciences, Inc (NASDAQ: PLSE), a burgeoning player in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative bioelectric..

Progyny, Inc. (PGNY) Stock Analysis: Potential 68% Upside with Strong Buy Ratings in Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY), a healthcare plans company specializing in fertility and family-building benefits, is drawing attention with a notable potential upside of 68.39%, according to..

Vera Therapeutics, Inc. (VERA) Stock Analysis: 94.88% Potential Upside Signals Compelling Opportunity

Vera Therapeutics, Inc. (NASDAQ: VERA), a biotechnology company strategically positioned in the healthcare sector, is catching the eye of investors with a striking potential upside of..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Biotech Gem with 51% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is gaining traction among investors as a promising player in the biotechnology sector. With a current market cap of $2.9 billion,..

ANI Pharmaceuticals (ANIP) Stock Analysis: A Compelling 47% Upside Potential Awaits Investors

For investors seeking opportunities in the healthcare sector, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling case. With a potential upside of 47.07%, as indicated by..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Unveiling a 29% Upside Potential for Savvy Investors

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is garnering attention with its robust 29.39% potential upside, according to recent analyst ratings...

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 37.76% Potential Upside

Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, is capturing investor attention with a compelling potential upside of 37.76%. Known for its..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 44.65% Potential Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 44.65% based on current..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Navigating a 38.97% Potential Upside Amid Biotech Challenges

Investors eyeing the healthcare sector may find ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) an intriguing prospect. With a market capitalization of $3.86 billion, ACADIA stands as a..

Twist Bioscience Corporation (TWST) Stock Analysis: A Look at the 8.71% Potential Upside in the Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, specifically within the diagnostics and research industry, as it continues to capture the interest..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Strong Buy Ratings and a Promising 14.42% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biotechnology firm specializing in peptide-based therapeutics, is capturing investor attention with its dynamic pipeline and robust analyst support. With a..

Premier, Inc. (PINC) Stock Analysis: Navigating a Stable Yet Cautious Path in Healthcare

Premier, Inc. (NASDAQ: PINC) stands as a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.34..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds